Added to YB: 2024-09-30
Pitch date: 2024-09-26
LFCR [bullish]
Lifecore Biomedical, Inc.
+62.29%
current return
Author Info
Byron Street Research is an investment publication featuring a weekly event-driven idea generator, write-ups modeled in the familiar format of sell-side equity research reports, and performance reviews structured as traditional fund factsheets. Sign up for the newsletter.
Company Info
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.
Market Cap
$298.2M
Pitch Price
$4.80
Price Target
7.42 (-5%)
Dividend
N/A
EV/EBITDA
-128.16
P/E
-6.25
EV/Sales
3.62
Sector
Life Sciences Tools and Services
Category
growth
Lifecore Biomedical, Inc. - $LFCR
LFCR: Pure-play CDMO post-divestiture. New CEO w/ 30yr exp. Catalysts: industry consolidation, reshoring, BIOSECURE Act, HA demand, sterile injectable shortages. Capacity expanding 45mm to 70mm units by FY27 (current demand 11mm). Improved liquidity. Double-digit growth potential beyond FY25. PT $7.42.
Read full article (2 min)